Tildrakizumab in Complex Psoriatic Patients: An Experience in Emilia-Romagna (Italy).

Federico BardazziFilippo VivianiBianca Maria PiracciniClaudia LasagniLaura BigiMarco ManfrediniLinda PongettiVito Di LerniaMonica CorazzaFrancesca Pepe

Published in: Journal of cutaneous medicine and surgery (2023)

we assessed a good performance of tildrakizumab in patients with multiple comorbidities, multi-failure, elderly patients, and in subjects with psoriatic arthritis.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
disease activity
systemic lupus erythematosus
ankylosing spondylitis
patient reported outcomes